Clinical trial • Phase I • Musculoskeletal
Clinical trial in Osteochondritis dissecans | Femoral cartilage lesion (knee)
Phase I trial for Osteochondritis dissecans | Femoral cartilage lesion (knee). 6 participants.
Overview
- Trial Therapeutic Area
- Musculoskeletal
- Trial Disease
- Osteochondritis dissecans | Femoral cartilage lesion (knee)
- Trial Stage
- Phase I
- Drug Modality
- Cell therapy | Other
Key dates
- Initial CTIS Submission Date
- 02-05-2024
- First CTIS Authorization Date
- 09-10-2024
Trial design
Phase I trial across 1 site in France.
- Target Sample Size
- 6
Recruitment
- Planned Sample Size
- 6
- Recruitment Window Months
- 35
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 6
France
- Earliest CTIS Part Ii Submission Date
- 15-05-2024
- Latest Decision Or Authorization Date
- 05-06-2025
- Processing Time Days
- 386
- Number Of Sites
- 1
- Number Of Participants
- 6
Sites
- Site Name
- Hopital de Hautepierre Strasbourg
- Department Name
- Orthopedic department
- Contact Person Name
- Matthieu EHLINGER
- Contact Person Email
- matthieu.ehlinger@chru-strasbourg.fr
- Number Of Participants
- 6
Sponsor
Primary sponsor
- Full Name
- Lamina Therapeutics
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- France
Investigational products
- Combination Treatment
- Yes
Related trials
Other published trials that may interest you.